The global chromatography resin market size is expected to reach USD 3.94 billion by 2030 and expand at a CAGR of 6.8% according to the report. The growth is majorly driven by constantly increasing need for drug development activities for the production of biopharma and biological products for diagnostics.
Chromatography technique is used in therapeutic drug monitoring, which is used when a patient is on toxic medication to analyze the blood and urine levels. Tests such as blood, urine, stool, and umbilical cord on a regular basis are beneficial to ensure that the patient is taking an appropriate dose of medication. These technique helps companies develop and manufacture biological pharmaceutical tools to achieve safety and quality of active ingredients.
In North America, the pharmaceutical industry has been advancing for years and has grown at a faster rate, resulting in booming demand for ion exchange chromatography resin. Additionally, high healthcare spending and the presence of major pharmaceutical market leaders in the U.S. is the main driver of the chromatography resin market in the North America region.
Some of the key players operating in the industry are constantly undertaking initiatives to develop more effective and innovative products in an attempt to strengthen their position in the global market. In Covid-19 pandemic the chromatography resin manufacturers including Purolite, TriAltus Biosciences, and Avantor were majorly engaged in R&D activities for new product development. For instance, TriAltus Biosciences, a developer of innovative tools for protein purification developed novel CL7/Im7 system a protein purification technology. This technology was developed to aid the cancer institute for Covid-19 vaccine development.
Chromatography technique is used in therapeutic drug monitoring, which is used when a patient is on toxic medication to analyze the blood and urine levels. Tests such as blood, urine, stool, and umbilical cord on a regular basis are beneficial to ensure that the patient is taking an appropriate dose of medication. These technique helps companies develop and manufacture biological pharmaceutical tools to achieve safety and quality of active ingredients.
In North America, the pharmaceutical industry has been advancing for years and has grown at a faster rate, resulting in booming demand for ion exchange chromatography resin. Additionally, high healthcare spending and the presence of major pharmaceutical market leaders in the U.S. is the main driver of the chromatography resin market in the North America region.
Some of the key players operating in the industry are constantly undertaking initiatives to develop more effective and innovative products in an attempt to strengthen their position in the global market. In Covid-19 pandemic the chromatography resin manufacturers including Purolite, TriAltus Biosciences, and Avantor were majorly engaged in R&D activities for new product development. For instance, TriAltus Biosciences, a developer of innovative tools for protein purification developed novel CL7/Im7 system a protein purification technology. This technology was developed to aid the cancer institute for Covid-19 vaccine development.
Chromatography Resin Market Report Highlights
- Asia Pacific is expected to witness fastest growth rate globally with a CAGR of 7.5% in terms of revenue for the forecast period. This is attributable to government initiatives in Asian countries, especially in China and India, to give a boost to the pharmaceutical industry
- Ion exchange technique is anticipated to exhibit rapid growth rate with a CAGR of 7.7% in terms of revenue from 2023 to 2030. This is owed to rapid growth in drug discovery activities in developed as well as developing economies worldwide
- Pharmaceutical & biotechnology end-use segment contributed to the highest share accounting to more than 83% from 2023 to 2030, owing to constant demand from pharmaceutical companies and CROs for drug discovery processes
- Furthermore, the food & beverages segment is witnessed a growth rate 7.5% in terms of revenue. This high growth rate is attributable to growing application in F&B processes such as detection of aflatoxins in foods, vitamin separation, amino acid analysis, profiling food components, analysis of colorants and residues, sugar content analysis, and others
- Natural segment appeared to have largest contribution to the global revenue share with more than 51%. This high share is attributable to the growing demand for natural resin obtained from natural sources which comply the regulatory support for use in various applications, which further complements the segment growth
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Chromatography Resin Market: Market Variables, Trends & Scope
Chapter 4 Chromatography Resin Market: Supplier Portfolio Analysis
Chapter 5 Chromatography Resin Market: Type Estimates & Trend Analysis
Chapter 6 Chromatography Resin Market: Technique Estimates & Trend Analysis
Chapter 7 Chromatography Resin Market: End-use Estimates & Trend Analysis
Chapter 8 Chromatography Resins Market: Regional Estimates & Trend Analysis
Chapter 9 Competitive Landscape
List of Tables
List of Figures
Companies Profiled
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- GE Healthcare
- Purolite Corporation
- W. R. Grace & Co.
- Mitsubishi Chemical Corporation
- Tosoh Corporation
- Danaher Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | November 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.47 Billion |
| Forecasted Market Value ( USD | $ 3.94 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
